Jury still out on IL-6 drugs in COVID-19 following preliminary trial results

Jury still out on IL-6 drugs in COVID-19 following preliminary trial results

Source: 
Pharmaforum
snippet: 

There is a growing body of evidence that already-approved IL-6 could be used as treatments for COVID-19 following newly published clinical trial data – but the jury is out on whether they could be licensed in the new use until larger trial results are published in the coming weeks.